プロテオミクス市場規模、シェア、動向分析レポート：製品・サービス別、技術別、用途別、地域別、セグメント予測、2025年～2030年

プロテオミクス市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のプロテオミクス市場規模は2030年に581億6,000万米ドルに達すると予測され、2025～2030年にかけて12.9％のCAGRで成長すると予測されています。

同産業の成長を牽引する主要因は、個別化医療に対する需要の高まり、プロテオミクス質量分析計やバイオチッププラットフォームを活用した診断のパイプラインの拡大、ゲノミクスによる発見です。さらに、医薬品開発におけるプロテオミクスの重要性から、多くの製薬会社が独自のプロテオミクス部門を設立しており、これが世界の産業の拡大に拍車をかけています。例えば、2021年9月、Biognosysは、臨床研究と創薬における次世代プロテオミクスの利用を促進するため、Evotecとの提携を発表しました。

世界中の研究者がSARS-CoV-2タンパク質の3D構造の解読に集中していることから、COVID-19の発生は産業に大きな影響を与えると予想されます。COVID-19に対する効果的な医薬品や生物製剤を開発するために、科学者たちはこれらのタンパク質の同定技術、構造、特性、相互作用の検討も試みています。ウイルスの新規で効率的な標的治療を見つけるためには、ウイルスタンパク質の構造とその特定の位置を理解する必要があります。したがって、COVID-19の医薬品開発需要が増加し、産業の成長が促進されます。また、特注薬に対するニーズの高まりによる研究開発費の増加、プロテオミクスコンポーネントに関する技術開発も市場を牽引しています。

さらに、質量分析ベースのプロテオミクスの改良とバイオマーカー同定に関連する有利な機会から、プロテオミクスの魅力的な市場拡大の可能性が見込まれます。主要な市場参入企業による新しく改良されたプロテオミクス技術の導入は、産業の成長をさらに加速させると予測されています。例えば、ショットガンプロテオミクスに迅速なデータ取得を提供するために、Bruker Corp.は2017年9月にPASEF（Parallel Accumulation And Serial Fragmentation）質量分析用のtimsTOF Proシステムを発表しました。このシステムは、独自のTrapped Ion Mobility Spectrometry（TIMS）技術を使用しています。さらに、プロテオミクス研究の進歩により、タンパク質バイオマーカーの検出、タンパク質バイオチップ＆ファーマコプロテオミクス、プロテオミクスによる分子診断が加速しており、これらはいずれも個別化医療の発展に大きく貢献しています。

プロテオミクス市場レポートハイライト

• 心血管疾患、糖尿病、がんなどの慢性疾患は、世界の罹患率と死亡率のかなりの部分を占めています。
• プロテオミクス産業は、質量分析と次世代シーケンス技術の技術的進歩に牽引され、大きな技術革新を経験しています。
• 試薬・消耗品セグメントは、2024年に72.53%の最大の収益シェアを占めました。質量分析用に設計されたキットは、研究者が複雑な生物学的サンプル内のタンパク質を正確に同定することを可能にします。
• スペクトロメトリー部門は、2024年に31.88％の最大収益シェアを獲得しました。また、予測期間中はさらに最高値で拡大すると予測されています。
• 創薬セグメントは、2024年に52.73%の最大の収益シェアを獲得し、プロテオミクス市場を独占しました。この大きなシェアは、構造ベースの薬剤設計の開発、個別化された薬剤の作成の重視、これらのセグメントへの投資の増加に起因しています。
• 北米プロテオミクス市場は世界市場を独占し、2024年の売上高シェアは45.75%でした。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 プロテオミクス市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/補助的な市場展望
• 市場力学
  • 市場の促進要因分析
  • 市場抑制要因分析
• プロテオミクス市場分析ツール
  • 産業分析-ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 プロテオミクス市場：製品・サービス別、推定・動向分析

• セグメントダッシュボード
• 世界のプロテオミクス市場の製品・サービス変動分析
• 世界のプロテオミクス市場規模と動向分析（製品・サービス別、2018～2030年）
• 機器
• 試薬と消耗品
• サービス

第5章 プロテオミクス市場：用途別、推定・動向分析

• セグメントダッシュボード
• 世界のプロテオミクス市場の用途変動分析
• 世界のプロテオミクス市場規模と動向分析（用途別、2018～2030年）
• 創薬
• 臨床診断
• その他

第6章 プロテオミクス市場：技術別、推定・動向分析

• セグメントダッシュボード
• 世界のプロテオミクス市場の技術変動分析
• 世界のプロテオミクス市場規模と動向分析（技術別、2018～2030年）
• 次世代シーケンス
• マイクロアレイ機器
• X線結晶構造分析
• 分光分析
• クロマトグラフィー
• タンパク質分画システム
• 電気泳動
• 表面プラズマ共鳴（SPR）システム
• その他

第7章 プロテオミクス市場：地域別、推定・動向分析

• 地域別市場シェア分析、2024年と2030年
• 地域別市場ダッシュボード
• 市場規模、予測動向分析、2018～2030年
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 企業/競合の分類
• 戦略マッピング
• 企業市況分析、2024年
• 企業プロファイル/上場企業
  • Illumina Inc.
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific, Inc.
  • Bruker Corporation
  • F. Hoffmann-La Roche Ltd.
  • Waters Corporation
  • Merck KGaA
  • Danaher
  • Standard BioTools Inc.

List of Tables

• Table 1 List of abbreviation
• Table 2 Global proteomics market, by region, 2018 - 2030 (USD Million)
• Table 3 Global proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 4 Global proteomics market, by application, 2018 - 2030 (USD Million)
• Table 5 Global proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 6 North America proteomics market, by country, 2018 - 2030 (USD Million)
• Table 7 North America proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 8 North America proteomics market, by application, 2018 - 2030 (USD Million)
• Table 9 North America proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 10 U.S. proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 11 U.S. proteomics market, by application, 2018 - 2030 (USD Million)
• Table 12 U.S. proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 13 Canada proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 14 Canada proteomics market, by application, 2018 - 2030 (USD Million)
• Table 15 Canada proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 16 Mexico proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 17 Mexico proteomics market, by application, 2018 - 2030 (USD Million)
• Table 18 Mexico proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 19 Europe proteomics market, by country, 2018 - 2030 (USD Million)
• Table 20 Europe proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 21 Europe proteomics market, by application, 2018 - 2030 (USD Million)
• Table 22 Europe proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 23 UK proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 24 UK proteomics market, by application, 2018 - 2030 (USD Million)
• Table 25 UK proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 26 Germany proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 27 Germany proteomics market, by application, 2018 - 2030 (USD Million)
• Table 28 Germany proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 29 France proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 30 France proteomics market, by application, 2018 - 2030 (USD Million)
• Table 31 France proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 32 Italy proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 33 Italy proteomics market, by application, 2018 - 2030 (USD Million)
• Table 34 Italy proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 35 Spain proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 36 Spain proteomics market, by application, 2018 - 2030 (USD Million)
• Table 37 Spain proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 38 Denmark proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 39 Denmark proteomics market, by application, 2018 - 2030 (USD Million)
• Table 40 Denmark proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 41 Sweden proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 42 Sweden proteomics market, by application, 2018 - 2030 (USD Million)
• Table 43 Sweden proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 44 Norway proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 45 Norway proteomics market, by application, 2018 - 2030 (USD Million)
• Table 46 Norway proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 47 Asia Pacific proteomics market, by country, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific proteomics market, by application, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 51 China proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 52 China proteomics market, by application, 2018 - 2030 (USD Million)
• Table 53 China proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 54 Japan proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 55 Japan proteomics market, by application, 2018 - 2030 (USD Million)
• Table 56 Japan proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 57 India proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 58 India proteomics market, by application, 2018 - 2030 (USD Million)
• Table 59 India proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 60 South Korea proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 61 South Korea proteomics market, by application, 2018 - 2030 (USD Million)
• Table 62 South Korea proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 63 Australia proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 64 Australia proteomics market, by application, 2018 - 2030 (USD Million)
• Table 65 Australia proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 66 Thailand proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 67 Thailand proteomics market, by application, 2018 - 2030 (USD Million)
• Table 68 Thailand proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 69 Latin America proteomics market, by country, 2018 - 2030 (USD Million)
• Table 70 Latin America proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 71 Latin America proteomics market, by application, 2018 - 2030 (USD Million)
• Table 72 Latin America proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 73 Brazil proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 74 Brazil proteomics market, by application, 2018 - 2030 (USD Million)
• Table 75 Brazil proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 76 Argentina proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 77 Argentina proteomics market, by application, 2018 - 2030 (USD Million)
• Table 78 Argentina proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 79 MEA proteomics market, by country, 2018 - 2030 (USD Million)
• Table 80 MEA proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 81 MEA proteomics market, by application, 2018 - 2030 (USD Million)
• Table 82 MEA proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 83 South Africa proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 84 South Africa proteomics market, by application, 2018 - 2030 (USD Million)
• Table 85 South Africa proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 86 Saudi Arabia proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia proteomics market, by application, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 89 UAE proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 90 UAE proteomics market, by application, 2018 - 2030 (USD Million)
• Table 91 UAE proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 92 Kuwait proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 93 Kuwait proteomics market, by application, 2018 - 2030 (USD Million)
• Table 94 Kuwait proteomics market, by technology, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Market formulation & validation
• Fig. 4 Proteomics market: Market outlook
• Fig. 5 Proteomics market: Segment outlook
• Fig. 6 Proteomics market: Competitive landscape outlook
• Fig. 7 Parent market outlook
• Fig. 8 Proteomics market driver impact
• Fig. 9 Proteomics market restraint impact
• Fig. 10 Proteomics market: Product & service outlook and key takeaways
• Fig. 11 Proteomics market: Product & service movement analysis
• Fig. 12 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 13 Reagents & consumables market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 14 Services market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 15 Proteomics market: Application outlook and key takeaways
• Fig. 16 Proteomics market: Application movement analysis
• Fig. 17 Drug discovery market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 18 Clinical diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 19 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 20 Proteomics market: Technology outlook and key takeaways
• Fig. 21 Proteomics market: Technology movement analysis
• Fig. 22 Next-generation sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23 Microarray instruments market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 24 X-ray crystallography market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 Spectrometry market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26 Chromatography market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 27 Protein fractionation systems market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 28 Electrophoresis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 29 Surface plasma resonance (SPR) systems market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 30 Other technologies market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 31 Global proteomics market: Regional outlook and key takeaways
• Fig. 32 Global proteomics market: Regional movement analysis
• Fig. 33 North America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Key country dynamics
• Fig. 35 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Key country dynamics
• Fig. 37 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Key country dynamics
• Fig. 39 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Key country dynamics
• Fig. 42 UK market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Key country dynamics
• Fig. 44 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 Key country dynamics
• Fig. 46 France market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Key country dynamics
• Fig. 48 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Key country dynamics
• Fig. 50 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Key country dynamics
• Fig. 52 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Key country dynamics
• Fig. 54 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Key country dynamics
• Fig. 56 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Key country dynamics
• Fig. 59 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Key country dynamics
• Fig. 61 China market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 62 Key country dynamics
• Fig. 63 India market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 64 Key country dynamics
• Fig. 65 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 66 Key country dynamics
• Fig. 67 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 68 Key country dynamics
• Fig. 69 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 70 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 71 Key country dynamics
• Fig. 72 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 73 Key country dynamics
• Fig. 74 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 75 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 76 Key country dynamics
• Fig. 77 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 78 Key country dynamics
• Fig. 79 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 80 Key country dynamics
• Fig. 81 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 82 Key country dynamics
• Fig. 83 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Proteomics Market Growth & Trends:

The global proteomics market size is expected to reach USD 58.16 billion in 2030 and is projected to grow at a CAGR of 12.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The major factors driving theindustry growth are a rise in the demand for personalized medicine, an expansion of the pipeline of diagnostics utilizing proteomics mass spectrometry as well as biochip platforms, and discoveries based on genomics. Moreover, owing to the importance of proteomics in drug development, numerous pharmaceutical companies have established their own proteomic divisions, which are fueling the expansion of the global industry. For instance, in September 2021, Biognosys, announced the collaboration with Evotec, to promote the use of next-generation proteomics in clinical research and drug discovery.

The COVID-19 outbreak is expected to have a significant impact on the industry, as researchers across the world are concentrating on decoding 3D structures of SARS-CoV-2 proteins. To create effective medications and biological products against COVID-19, scientists are also attempting to examine the identification techniques, structures, characterization, and interactions of these proteins. The protein structure of virus proteins and their specific locations must be understood to find a novel, efficient target treatment medication for a virus. Therefore, it will increase the demand for drug development for COVID-19 and propel industry growth. The growing need for customized medications increased R&D spending, and technological developments related to proteomics components are also driving the market.

In addition, attractive market expansion potential for proteomics is anticipated to come from improvements in mass spectrometry-based proteomics and lucrative opportunities related to biomarker identification. Thereby, propelling the market growth.The introduction of new and improved proteomics techniques by major industry participants is projected to further accelerate the growth of the industry. For instance, to provide quick data acquisition for shotgun proteomics, Bruker Corp. introduced the timsTOF Pro system for Parallel Accumulation And Serial Fragmentation (PASEF) mass spectrometry in September 2017. This system uses proprietary Trapped Ion Mobility Spectrometry (TIMS) technology.Furthermore, proteomic research advancements have accelerated the detection of protein biomarkers, protein biochips & pharmacoproteomics, and proteomics-based molecular diagnostics, which have all made significant contributions to the development of personalized medicine.

Proteomics Market Report Highlights:

• Chronic diseases, such as cardiovascular conditions, diabetes, and cancer, account for a substantial portion of global morbidity and mortality.
• The proteomics industry is experiencing a significant degree of innovation driven by technological advancements in mass spectrometry and next-generation sequencing technology.
• The reagents & consumables segment accounted for the largest revenue share of 72.53% in 2024. Kits designed for mass spectrometry enable researchers to identify proteins within complex biological samples accurately
• The spectrometry segment captured the largest revenue share of 31.88% in 2024. It is also expected to expand further at the highest during the forecast period
• The drug discovery segment dominated the proteomics market with the largest revenue share of 52.73% in 2024. This large share can be attributed to the development of structure-based drug design, a greater emphasis on creating personalized drugs, and increased investments in these areas.
• North America Proteomics market dominated the global market and accounted for 45.75% revenue share in 2024, owing to the advancements in technology and growing demand for advanced disease diagnostics

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Product & Service Segment
  • 1.2.2. Application Segment
  • 1.2.3. Technology Segment
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. Proteomics Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising prevalence of chronic and infectious diseases
    • 3.2.1.2. Growing preference for personalized medicine
    • 3.2.1.3. Technological advancements in proteomics techniques
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of proteomics tools and instruments
• 3.3. Proteomics Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Proteomics Market: Product & Service Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Proteomics Market Product & Service Movement Analysis
• 4.3. Global Proteomics Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
• 4.4. Instruments
  • 4.4.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Reagents & Consumables
  • 4.5.1. Reagents & consumables market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Services
  • 4.6.1. Services market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Proteomics Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Proteomics Market Application Movement Analysis
• 5.3. Global Proteomics Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Drug Discovery
  • 5.4.1. Drug discovery market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Clinical Diagnostics
  • 5.5.1. Clinical diagnostics market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Others
  • 5.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Proteomics Market: Technology Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Proteomics Market Technology Movement Analysis
• 6.3. Global Proteomics Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
• 6.4. Next-generation Sequencing
  • 6.4.1. Next-generation sequencing market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Microarray Instruments
  • 6.5.1. Microarray instruments market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. X-ray Crystallography
  • 6.6.1. X-ray crystallography market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Spectrometry
  • 6.7.1. Spectrometry market estimates and forecasts 2018 to 2030 (USD Million)
• 6.8. Chromatography
  • 6.8.1. Chromatography market estimates and forecasts 2018 to 2030 (USD Million)
• 6.9. Protein Fractionation Systems
  • 6.9.1. Protein fractionation systems market estimates and forecasts 2018 to 2030 (USD Million)
• 6.10. Electrophoresis
  • 6.10.1. Electrophoresis market estimates and forecasts 2018 to 2030 (USD Million)
• 6.11. Surface Plasma Resonance (SPR) Systems
  • 6.11.1. Surface plasma resonance (SPR) systems market estimates and forecasts 2018 to 2030 (USD Million)
• 6.12. Other Technologies
  • 6.12.1. Other technologies market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Proteomics Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.4. North America
  • 7.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. U.S.
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Competitive scenario
    • 7.4.2.3. Regulatory framework
    • 7.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.3. Canada
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Competitive scenario
    • 7.4.3.3. Regulatory framework
    • 7.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.4. Mexico
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Competitive scenario
    • 7.4.4.3. Regulatory framework
    • 7.4.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Competitive scenario
    • 7.5.2.3. Regulatory framework
    • 7.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. Germany
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Competitive scenario
    • 7.5.3.3. Regulatory framework
    • 7.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Competitive scenario
    • 7.5.4.3. Regulatory framework
    • 7.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Competitive scenario
    • 7.5.5.3. Regulatory framework
    • 7.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.6. Spain
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Competitive scenario
    • 7.5.6.3. Regulatory framework
    • 7.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.7. Norway
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Competitive scenario
    • 7.5.7.3. Regulatory framework
    • 7.5.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.8. Sweden
    • 7.5.8.1. Key country dynamics
    • 7.5.8.2. Competitive scenario
    • 7.5.8.3. Regulatory framework
    • 7.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.9. Denmark
    • 7.5.9.1. Key country dynamics
    • 7.5.9.2. Competitive scenario
    • 7.5.9.3. Regulatory framework
    • 7.5.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive scenario
    • 7.6.2.3. Regulatory framework
    • 7.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Competitive scenario
    • 7.6.3.3. Regulatory framework
    • 7.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Competitive scenario
    • 7.6.4.3. Regulatory framework
    • 7.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.5. Australia
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Competitive scenario
    • 7.6.5.3. Regulatory framework
    • 7.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.6. South Korea
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Competitive scenario
    • 7.6.6.3. Regulatory framework
    • 7.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Competitive scenario
    • 7.6.7.3. Regulatory framework
    • 7.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Regulatory framework
    • 7.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive scenario
    • 7.7.3.3. Regulatory framework
    • 7.7.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.8. MEA
  • 7.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Competitive scenario
    • 7.8.2.3. Regulatory framework
    • 7.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Competitive scenario
    • 7.8.3.3. Regulatory framework
    • 7.8.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key country dynamics
    • 7.8.4.2. Competitive scenario
    • 7.8.4.3. Regulatory framework
    • 7.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key country dynamics
    • 7.8.5.2. Competitive scenario
    • 7.8.5.3. Regulatory framework
    • 7.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company/Competition Categorization
• 8.2. Strategy Mapping
• 8.3. Company Market Position Analysis, 2024
• 8.4. Company Profiles/Listing
  • 8.4.1. Illumina Inc.
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product/Service benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Agilent Technologies Inc.
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product/Service benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. Bio-Rad Laboratories, Inc.
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product/Service benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. Thermo Fisher Scientific, Inc.
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product/Service benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. Bruker Corporation
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product/Service benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. F. Hoffmann-La Roche Ltd.
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product/Service benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Waters Corporation
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product/Service benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. Merck KGaA
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product/Service benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Danaher
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product/Service benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. Standard BioTools Inc.
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Product/Service benchmarking
    • 8.4.10.4. Strategic initiatives